Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astonea LabsBOM:544409 12 PB Ratio is 5.04 as of Jul. 31, 2026, which is 59% above its 10-year median of 3.16. GuruFocus rates BOM:544409 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 921 Drug Manufacturers companies, Astonea Labs ranks worse than 82.74% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-31), Astonea Labs's share price is ₹273.75. Astonea Labs's Book Value per Share for the quarter that ended in Mar. 2026 was ₹54.35. Hence, Astonea Labs's PB Ratio of today is 5.04.
The historical rank and industry rank for Astonea Labs's PB Ratio or its related term are showing as below:
BOM:544409'
s PB Ratio Range Over the Past 10 Years
Min: 2.79 Med: 3.16 Max: 10.41
Current: 5.04
During the past 5 years, Astonea Labs's highest PB Ratio was 10.41. The lowest was 2.79. And the median was 3.16.
BOM:544409's PB Ratio is ranked worse than 82.74% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.86
vs BOM:544409: 5.04
During the past 12 months, Astonea Labs's average Book Value Per Share Growth Rate was 210.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 91.30% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Astonea Labs was 91.30% per year. The lowest was 34.90% per year. And the median was 63.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Astonea Labs PB Ratio Related Terms
Astonea Labs PB Ratio Historical Data
* Premium members only.
The historical data trend for Astonea Labs's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Astonea Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astonea Labs PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Astonea Labs's PB Ratio distribution charts can be found below:
* The bar in red indicates where Astonea Labs's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Astonea Labs's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Astonea Labs (BOM:544409) has a PB Ratio of 5.04 as of Jul. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astonea Labs and its competitors. This is 59% above median its historical median of 3.16. Over the past decade, Astonea Labs' PB Ratio has ranged from 2.79 to 10.41. According to the industry distribution chart, Astonea Labs ranks #762 out of 921 companies in the Drug Manufacturers industry, placing it in the top 82.7%.
Is Astonea Labs' PB Ratio too high?
Astonea Labs' current PB Ratio of 5.04 is 59% above median its 10-year median of 3.16. Over the past 10 years, this metric has ranged from a low of 2.79 to a high of 10.41. The Drug Manufacturers industry median PB Ratio is 1.86. Astonea Labs' value of 5.04 is 171% above this industry median. Based on the distribution chart, Astonea Labs ranks #762 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Astonea Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Astonea Labs' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Astonea Labs ranks #762 out of 921 companies for PB Ratio. This places Astonea Labs in the lower half of its industry. The industry median PB Ratio is 1.86. Astonea Labs' value of 5.04 is 171% above this benchmark. Historically, Astonea Labs' own PB Ratio has ranged from 2.79 to 10.41 over the past decade. While the company's 10-year median is 3.16 vs. the industry median of 1.86, Astonea Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astonea Labs's current PB Ratio of 5.04 is 171% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astonea Labs and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astonea Labs's current PB Ratio is 5.04, which is 59% above median its own 10-year median of 3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astonea Labs stock overvalued right now?
Astonea Labs (BOM:544409) has a current PB Ratio of 5.04. The current PB Ratio is 5.04, which is 59% above median its 10-year median of 3.16 and 171% above the Drug Manufacturers industry median of 1.86. Astonea Labs' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Astonea Labs (BOM:544409), the current PB Ratio is 5.04 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Astonea Labs Ltd is an India-based pharmaceutical and cosmetics company engaged in the manufacturing and development of healthcare and personal care products. The Company operates in the pharmaceuticals and cosmetics & personal care space, offering products that include generic medicines, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as skincare, haircare, anti-aging, ethical, and organic cosmetic products, supported by in-house research and development and contract manufacturing services. Its business activities are organized across key segments comprising Pharmaceuticals, Cosmetics & Personal Care, R&D & Innovation, and Contract Manufacturing (CDMO).
12GF Score
Get the complete analysis for BOM:544409
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544409 has been successfully added to your 
